Localization of latent transforming growth factor-β binding protein-1 in human coronary atherosclerotic plaques

Circulation Journal

Volumn 75, Issue 1, 2011, Pages 196-200

  Öklü, Rahmi ^a   Hesketh, Robin ^b   Wicky, Stephan ^a   Metcalfe, James C ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Atherosclerosis; Coronary heart disease; Genes; Immunohistochemistry; Molecular biology

Indexed keywords

LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 1; MESSENGER RNA; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

CORONARY ARTERY DISEASE; CORONARY VESSELS; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LATENT TGF-BETA BINDING PROTEINS; RNA, MESSENGER; TUNICA INTIMA; TUNICA MEDIA;

EID: 78651225686     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0334     Document Type: Article

References (30)

1. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998; 67: 753-791.
2. Bjorkerud S. Effects of transforming growth factor-beta 1 on human arterial smooth muscle cells in vitro. Arterioscler Thromb 1991; 11: 892-902.
3. Sato Y, Rifkin DB. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J Cell Biol 1989; 109: 309-315.
4. Kirschenlohr HL, Metcalfe JC, Weissberg PL, Grainger DJ. Proliferation of human aortic vascular smooth muscle cells in culture is modulated by active TGF beta. Cardiovasc Res 1995; 29: 848-855.
5. Grainger DJ, Metcalfe JC, Grace AA, Mosedale DE. Transforming growth factor-beta dynamically regulates vascular smooth muscle differentiation in vivo. J Cell Sci 1998; 111: 2977-2988.
6. Shimada K. Immune system and atherosclerotic disease. Circ J 2009; 73: 994-1001.
7. Fujita M, Sasayama S. Coronary collateral growth and its therapeutic application to coronary artery disease. Circ J 2010; 74: 1283-1289.
8. Muto A, Model L, Ziegler K, Eghbalieh S, Dardik A. Mechanisms of vein graft adaptation to the arterial circulation. Circ J 2010; 74: 1501-1512.
9. Bobik A, Agrotis A, Kanellakis P, Dilley R, Krushinsky A, Smirnov V, et al. Distinct patterns of transforming growth factor-beta iso-form and receptor expression in human atherosclerotic lesions: Colocalization implicates TGF-beta in fibrofatty lesion development. Circulation 1999; 99: 2883-2891.
10. Ihling C, Technau K, Gross V, Schulte-Monting J, Zeiher AM, Schaefer HE. Concordant upregulation of type II-TGF-beta-recep-tor, the cyclin-dependent kinases inhibitor P27Kip1 and cyclin E in human atherosclerotic tissue: Implications for lesion cellularity. Atherosclerosis 1999; 144: 7-14.
11. McCaffrey TA, Du B, Consigli S, Szabo P, Bray PJ, Hartner L, et al. Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells. J Clin Invest 1997; 100: 2182-2188.
12. McCaffrey TA, Du B, Fu C, Bray PJ, Sanborn TA, Deutsch E, et al. The expression of TGF-beta receptors in human atherosclerosis: Evidence for acquired resistance to apoptosis due to receptor imbalance. J Mol Cell Cardiol 1999; 31: 1627-1642.
13. Massague J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990; 6: 597-641.
14. Olofsson A, Miyazono K, Kanzaki T, Colosetti P, Engstrom U, Heldin CH. Transforming growth factor-beta 1, -beta 2, and -beta 3 secreted by a human glioblastoma cell line: Identifcation of small and different forms of large latent complexes. J Biol Chem 1992; 267: 19482-19488.
15. Bottinger EP, Factor VM, Tsang ML, Weatherbee JA, Kopp JB, Qian SW, et al. The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice. Proc Natl Acad Sci USA 1996; 93: 5877-5882.
16. Gentry LE, Nash BW. The pro domain of pre-pro-transforming growth factor beta 1 when independently expressed is a functional binding protein for the mature growth factor. Biochemistry 1990; 29: 6851-6857.
17. Miyazono K, Olofsson A, Colosetti P, Heldin CH. A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1. EMBO J 1991; 10: 1091-1101.
18. Miyazono K, Thyberg J, Heldin CH. Retention of the transforming growth factor-beta 1 precursor in the Golgi complex in a latent endoglycosidase H-sensitive form. J Biol Chem 1992; 267: 5668-5675.
19. Flaumenhaft R, Abe M, Sato Y, Miyazono K, Harpel J, Heldin CH, et al. Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells. J Cell Biol 1993; 120: 995-1002.
20. Taipale J, Lohi J, Saarinen J, Kovanen PT, Keski-Oja J. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem 1995; 270: 4689-4696.
21. Taipale J, Miyazono K, Heldin CH, Keski-Oja J. Latent transforming growth factor-beta 1 associates to fbroblast extracellular matrix via latent TGF-beta binding protein. J Cell Biol 1994; 124: 171-181.
22. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, et al. A defnition of advanced types of atherosclerotic lesions and a histological classifcation of atherosclerosis: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 1995; 15: 1512-1531.
23. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, et al. A defnition of initial, fatty streak, and intermediate lesions of atherosclerosis: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb 1994; 14: 840-856.
24. Oklu R, Metcalfe JC, Hesketh TR, Kemp PR. Loss of a consensus heparin binding site by alternative splicing of latent transforming growth factor-beta binding protein-1. FEBS Lett 1998; 425: 281-285.
25. Kanzaki T, Olofsson A, Moren A, Wernstedt C, Hellman U, Miyazono K, et al. TGF-beta 1 binding protein: A component of the large latent complex of TGF-beta 1 with multiple repeat sequences. Cell 1990; 61: 1051-1061.
26. Trezise AE, Linder CC, Grieger D, Thompson EW, Meunier H, Griswold MD, et al. CFTR expression is regulated during both the cycle of the seminiferous epithelium and the oestrous cycle of rodents. Nat Genet 1993; 3: 157-164.
27. Gabbiani G, Kocher O, Bloom WS, Vandekerckhove J, Weber K. Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. J Clin Invest 1984; 73: 148-152.
28. Miyazono K, Hellman U, Wernstedt C, Heldin CH. Latent high molecular weight complex of transforming growth factor beta 1: Purification from human platelets and structural characterization. J Biol Chem 1988; 263: 6407-6415.
29. Merten M, Pakala R, Thiagarajan P, Benedict CR. Platelet micropar-ticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation 1999; 99: 2577-2582.
30. Grainger DJ, Mosedale DE, Metcalfe JC. TGF-beta in blood: A complex problem. Cytokine Growth Factor Rev 2000; 11: 133-145.